Advanced search
Publication Cover
Cancer Investigation Volume 9, 1991 - Issue 1
Submit an article Journal homepage
6
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Protracted Infusion of 5-FU with Weekly Low-Dose Cisplatin as Second-Line Therapy in Patients with Metastatic Colorectal Cancer Who Have Failed 5-FU Monotherapy

James D. Ahlgren Division of Hematology-Oncology, The George Washington University Medical Center, Washington, DC, 20007
,
Orrawin Trocki Division of Medical Oncology, Georgetown University Hospital, Washington, DC, 20007
,
John J. Gullo Hematology-Oncology Associates of Central New York, Syracuse, New York, 13210
,
Richard Goldberg Division of Hematology-Oncology, Geisinger Medical Center, Danville, Pennsylvania, 17822
,
W. Angus Muir Cancer Center of Virginia, Fredericksburg, Virginia, 22401
,
Regina Sisk Division of Medical Oncology, Georgetown University Hospital, Washington, DC, 20007
&
Lee Schacter Bristol-Myers Research Division, Wallingford, Connecticut, 06492
 show all
Pages 27-33 | Published online: 11 Jun 2009

References

  • Lokich JJ, Bothe A, Fine N, Perri J. Phase I study of protracted venous infusion of 5-fluorouracil. Cancer 1981; 48: 2565–2566
  • Wade JL, Herbst S, Greenburg A. Prolonged venous infusion (PVI) of 5-fluorouracil (5-FU) for metastatic colon cancer (MCC)–a follow-up report (Abstr). Proc Am Soc Clin Oncol 1988; 7: 94
  • Hansen E, Quebbeman R, Aussman R, et al. Continuous 5-fluorouracil (5-FU) infusion in colorectal cancer. Update of the MCW experience (Abstr). Proc Am Soc Clin Oncol 1987; 6: 80
  • Molina R, Fabian C, Slavik M, Dahlberg S. Reversal of palmarplantar erythrodysesthesia (PPE) by B6without loss of response in colon cancer patients receiving 200 mg/m2/day continuous 5-FU (Abstr). Proc Am Soc Clin Oncol 1987; 6: 90
  • Lokich JJ. Colorectal cancer. Cancer Chemotherapy by Infusion., JJ Lokich. Precept Press, Chicago 1987; 291–303
  • Belt RJ, Davidven ML, Myron MC, Barrett S. Continuous lowdose 5-fluorouracil (5-FU) for adenocarcinoma: confirmation of activity (Abstr). Proc Am Soc Clin Oncol 1985; 4: 90
  • Leichman L, Leichman CG, Kinzie J, et al. Long-term low-dose 5-fluorouracil (5-FU) in advanced measurable colon cancer: no correlation between toxicity and efficacy (Abstr). Proc Am Soc Clin Oncol 1985; 4: 86
  • Benedetto P, Davida E, Soloman J. Chronic continuous systemic infusion 5-fluorouracil (CCI-5-FU) in the treatment of metastatic colorectal carcinoma (CCA) (Abstr). Proc Am Soc Clin Oncol 1984; 3: 142
  • Lokich JJ, Ahlgren JD, Gullo JJ, et al. A prospective randomized comparison of continuous infusional 5-fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: A MidAtlantic Oncology Program study. J Clin Oncol 1989; 7: 425–432
  • Schabel FM, Jr., Trader MW, Laster WR, Jr, et al. Cis-dichlorodiammineplatinum (II): Combination chemotherapy and cross resistance studies with tumors of mice. Cancer Treat Rep 1979; 63: 1459–1473
  • Bergerat JP, Green C, Drewinko B. Combination chemotherapy in vitro. IV. Response of human colon carcinoma cells to combinations usingcis-diamminedichloroplatinum. Cancer Biochem Biophys 1979; 3: 173–180
  • Ortiz J, Woolley PV. A study of the synergistic cytotoxic effects of 5-fluorouracil and cisplatin against colon carcinoma cells using median effect analysis (Abstr). Proc Assoc Cancer Res 1987; 28: 414
  • Cantrell JE, Hart RD, Taylor RF, Harvey JC. Pilot trial of prolonged continuous-infusion 5-fluorouracil and weekly cisplatin in advanced colorectal cancer. Cancer Treat Rep 1987; 71: 615–618
  • Lokich J, Cantrell J, Ahlgren J, Phillips J. A phase II trial of protracted infusional 5-FU (PIF) vs PIF plus weekly bolus cisplatin (CDDP) in advanced measurable colon cancer (MAOP protocol 5286) (Abstr). Proc Soc Clin Oncol 1989; 8: 104
  • Lokich JJ, Moore C. Chemotherapy associated palmar-plantar erythsodysesthesia syndrome. Ann Intern Med 1984; 101: 798–800
  • Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481
  • Kish J, Drelichman A, Jacobs J, et al. Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck. Cancer Treat Rep 1982; 66: 471–474
  • Amrein PC, Wietzman SA. Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil. J Clin Oncol 1985; 3: 1632–1639
  • Hilgenberg AD, Carey RW, Wilkins EW, Jr, et al. Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann Thorac Surg 1988; 45: 357–363
  • Weiden PL, Einstein AB, Rudolph RH. Cisplatin bolus and 5-FU infusion chemotherapy for non-small cell lung cancer. Cancer Treat Rep 1985; 69: 1253–1255
  • Loehrer PJ, Turner S, Kubilis P, et al. A prospective randomized trial of fluorouracil versus fluorouracil plus cisplatin in the treatment of metastatic colorectal cancer. A Hoosier Oncology Group trial. J Clin Oncol 1988; 6: 642–648
  • Richards F, II, Beck J, Muss H, et al. Continuous infusion 5-fluorouracil (5-FU) with bolus cisplatin (P) in the treatment of metastatic colorectal cancer (Abstr). Proc Am Soc Clin Oncol 1988; 7: 96

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.